MarginsXMarginsX
Home › Markets › Health Care › FTRE

Fortrea Holdings Inc. (FTRE)

FTRE trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$19.79
-2.03% on the day
Market cap
$1.9B
Small cap
Revenue · 2025
$2.7B
+1.0% on 2024
Net income · 2025
-$986.2M
-36.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1965040/000162828026012244/0001628280-26-012244-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerFTRE on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001965040
SEC industry codeServices-Medical Laboratories

Financials · 2025

LineValue
Revenue$2.7B
Net income-$986.2M
Operating income-$872.6M
Net margin-36.2%
Operating margin-32.0%
Revenue growth+1.0%
Cash$174.6M
Total assets$2.7B
P/E (computed)Net income was not positive
P/S (computed)0.7×

Warning signs

Cash runway
Cash-flow positive
$220.6M cash at September 30, 2026
Share count, 1 year
+4.4%
2025-11-03 to 2026-10-27 · +8.7% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
-$4.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$220.6M cash; operating cash flow $50.5M a quarter.Report 2026-09-30
Shares outstanding96,500,000 (2026-10-27); 92,400,000 a year earlier; 88,800,000 three years earlier.Cover page 2026-10-27
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Raleigh, North Carolina, United StatesPCAOB Form AP 2026-03-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $4.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$691.5M$600K$60.8M$220.6M$1.1B$2.7B10-Q 2026-10-29
Q2 2026
2026-06-30
$678.2M-$13.2M$28.9M$168.6M$1.1B$2.7B10-Q 2026-07-29
Q1 2026
2026-03-31
$636.5M-$23.6M-$17.0M$147.5M$1.1B$2.7B10-Q 2026-05-05
Q4 2025
2025-12-31
$660.5M-$32.5M$129.1M$174.6M$1.1B$2.7B10-K 2026-02-26
Q3 2025
2025-09-30
$701.3M-$15.9M$86.8M$131.3M$1.1B$2.8B10-Q 2026-10-29
Q2 2025
2025-06-30
$710.3M-$374.9M$21.8M$81.2M$1.2B$2.7B10-Q 2026-07-29
Q1 2025
2025-03-31
$651.3M-$562.9M-$124.2M$101.6M$1.2B$2.7B10-Q 2026-05-05
Q4 2024
2024-12-31
$697.0M-$61.2M$17.1M$118.5M$1.1B$2.7B10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentDRS2023-02-13
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 338 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-8.0%
1 month-3.4%
3 months+13.4%
Year to date+17.1%
1 year+97.7%
From 52-week high-21.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
VCYTVeracyte Inc.$24.01-1.32%$1.9B
PSNLPersonalis Inc.$14.80-5.79%$1.6B
TRUPTrupanion Inc.$36.16+4.87%$1.6B
ALHCAlignment Healthcare Inc.$7.47+1.49%$1.6B
LMRILumexa Imaging Holdings Inc.$14.79-0.14%$1.4B
CLOVClover Health Investments Corp.$4.95-0.20%$2.7B
CELCCelcuity Inc.$60.57-5.90%$3.0B
FRNMFreenome Inc.$10.09-3.07%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier